Juvenile Arthritis

Top Story

Vitamin D deficiency linked to higher disease activity in JIA

January 14, 2019
In the Journals

PRINTO group proposes new, homogeneous list of JIA disorders

November 27, 2018
Researchers working with the Pediatric Rheumatology International Trials Organization have proposed a new, homogeneous list of four disorders that fall under juvenile…
FDA News

FDA approves prefilled autoinjector for Actemra

November 26, 2018
The FDA has approved ACTPen, a single-dose prefilled autoinjector of tocilizumab, for the treatment of adult patients with moderate to severe active rheumatoid arthritis…
In the Journals

Ilaris response maintained over 5 years in patients with JIA

November 20, 2018
Patients receiving the interleukin-1 inhibitor canakinumab for systemic juvenile idiopathic arthritis maintained or improved their response to the drug over 5 years…
More Headlines »

Highlights of the Rheumatology Summit: A Master Class in RA, PsA, and SpA

This activity is supported by independent educational grants from AbbVie; Celgene Corporation; Lilly USA, LLC; Merck & Co., Inc.; and Pfizer, Inc.

This CME-certified monograph is specifically designed for health care professionals to advance their knowledge…
More »
Meeting News Coverage

VIDEO: Silverman discusses immunology links between cancer treatments and rheumatic diseases

March 15, 2016
More »

AWIR 2nd Annual Immunology Bootcamp Part 3: Signal Transduction and Biosimilars

This activity is supported by educational grants from AbbVie, Inc.; Amgen; Bristol-Myers Squibb; Pfizer, Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis, vasculitis, and axial…
More »